Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

GOP Reps Call for an FDA Advisory Panel to Boost Agency Performance

March 21, 2013 12:07 pm | by Mass Device | News | Comments

A duo of House Energy & Commerce Committee Republicans announced this week that they plan to take a closer look at the FDA's life sciences initiatives, suggesting that the agency may need an advisory panel to watch its performance. Reps. Michael Burgess (R-Texas) and Joe Pitts (R-Pa.) committed to taking a stronger hand in oversight of the FDA.

TOPICS:

President Obama Views Demonstration of ReWalk Exoskeleton Technology During Visit to Israel

March 21, 2013 11:53 am | by ARGO Medical Technologies | News | Comments

ARGO Medical Technologies’ ReWalk exoskeleton was one of the cutting-edge Israeli inventions demonstrated to President Barack Obama in Israel during his visit to a session hosted by Technion-Israel Institute of Technology. ReWalk inventor Dr. Amit Goffer, an alumni of the Technion, is a quadriplegic who was inspired to invent the exoskeleton device because of his own personal story and experience.

TOPICS:

Mitek Sports Medicine Introduces New Interference Screw Design for Faster, Easier Insertion

March 21, 2013 11:29 am | by Mitek Sports Medicine | News | Comments

Mitek Sports Medicine, a leading developer and manufacturer of orthopaedic sports medicine products and soft tissue repair devices, has launched the MILAGRO Advance Interference Screw, a new biocomposite screw designed to offer easier and faster insertion when compared to traditional interference screws.

TOPICS:
Advertisement

Intermountain Medical Center Uses SynCardia Total Artificial Heart to Bridge 31-Year-Old Father to a Heart Transplant

March 21, 2013 11:24 am | by SynCardia Systems | News | Comments

SynCardia Systems announced today that Andrew Weaver, a 31-year-old husband and father of one who arrived at Intermountain Medical Center in Salt Lake City in grave condition, has been successfully bridged to a heart transplant with the SynCardia temporary Total Artificial Heart and discharged home.

TOPICS:

WPI and UMass Medical School Team Up to Improve Healthcare Delivery

March 21, 2013 11:22 am | by Worcester Polytechnic Institute | News | Comments

The Healthcare Delivery Institute is a multi-disciplinary organization that includes more than 20 research teams at WPI, external healthcare providers, and industry partners, all working to address the national and global challenge of creating the future of healthcare delivery.

TOPICS:

Medical Device Firm iTraumaCare Receives European Union CE Marking for iTClampTM Hemorrhage Control System

March 21, 2013 10:40 am | by The Associated Press | News | Comments

SAN ANTONIO--(BUSINESS WIRE)--Mar 21, 2013--iTraumaCare, an early-stage medical device firm focused on developing traumatic injury solutions for first responder and military medicine applications, has achieved its second regulatory milestone. The company received CE Mark approval to market its...

Washdown Shaft Collars

March 21, 2013 10:33 am | by MDT Staff | Ruland Manufacturing Co. | Product Releases | Comments

Ruland has developed a new shaft collar for high pressure washdown applications. Washdown shaft collars are a patent pending design containing a 303 stainless steel shaft collar, male and female shrouds made from FDA compliant materials, and three O-rings with FDA compliant lubrication.

Friction Positioning Hinges

March 21, 2013 10:19 am | by MDT Staff | Reell Precision Manufacturing Corp. | Product Releases | Comments

Reell “RT Series” friction positioning hinges introduce uniquely engineered constant torque solutions to precisely control and hold the angle of mounted components in any position.

Advertisement

Functional Characteristics of Antitumor T Cells Change With Increasing Time After Therapeutic Transfer

March 21, 2013 10:00 am | by AACR | News | Comments

Scientists have characterized how the functionality of genetically engineered T cells administered therapeutically to patients with melanoma changed over time. The data, which are published in Cancer Discovery, a journal of the American Association for Cancer Research, highlight the need for new strategies to sustain antitumor T cell functionality to increase the effectiveness of this immunotherapeutic approach.

TOPICS:

EarlySense Granted United States Patent for Respiratory Trend Analysis Capability for Contact-Free, Patient Safety Monitoring System

March 21, 2013 7:00 am | by The Associated Press | News | Comments

WALTHAM, Mass.--(BUSINESS WIRE)--Mar 21, 2013--EarlySense, the market leader in Proactive Patient Care Solutions™, announced today that the company has been granted a United States patent for the respiratory trend analysis component of its contact-free, patient safety monitoring system. The...

TOPICS:

MEDICREA Receives FDA Pediatric Clearance for PASS® LP Systems

March 21, 2013 3:30 am | by The Associated Press | News | Comments

LYON, France--(BUSINESS WIRE)--Mar 21, 2013--The MEDICREA group, listed on Alternext by NYSE Euronext Paris, a medical company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, announced today the FDA approval of the...

TOPICS:

33rd Annual ISICEM Conference Symposium Features Breakthrough Clinical Results Supporting OptiScanner™ from OptiScan Biomedical

March 21, 2013 3:00 am | by PR Newswire | News | Comments

BRUSSELS, Belgium, March 21, 2013 /PRNewswire/ -- OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the OptiScanner™, the company's first-of-its-kind automated, bedside glucose...

TOPICS:

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

March 20, 2013 7:44 pm | by PR Newswire | News | Comments

ABBOTT PARK, Ill., March 20, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted by majority (Yes: 5, No: 3) that the benefits of...

TOPICS:

FDA Panel Votes 5-3 that Benefits of Abbott's MitraClip Heart Implant Outweigh the Risks

March 20, 2013 6:55 pm | by Mass Device | News | Comments

The FDA's Circulatory System Devices Panel voted today to make its recommendation regarding Abbott's (NYSE:ABT) premarket approval application for the MitraClip heart implant, agreeing unanimously that the device is safe but issuing a mixed result on the effectiveness and potential risks of the device.

TOPICS:

Nanoparticles Show Which Way the Stem Cells Went

March 20, 2013 6:00 pm | by Massachusetts Institute of Technology | News | Comments

By monitoring the path of stem cells in the body, scientists can better explore experimental therapies, and doctors can better tune treatments in patients. Giving patients stem cells packaged with silica nanoparticles could help doctors determine the effectiveness of the treatments by revealing where the cells go after they’ve left the injection needle.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading